Product Details

Vericlin Capsules meet Indian Pharmacopoeia (IP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Clindamycin Hydrochloride equivalent to 300mg Clindamycin. As a result, it offers potent antibacterial coverage, particularly against anaerobic and certain resistant gram-positive organisms.

The capsules contain:

• Clindamycin Hydrochloride IP (equivalent to Clindamycin 300mg) – A lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Consequently, it exerts strong activity against anaerobic bacteria and many gram-positive cocci, including certain strains resistant to other antibiotic classes.

Physicians prescribe Vericlin for the treatment of serious anaerobic and gram-positive infections, including skin and soft tissue infections, dental and bone infections, and certain respiratory tract infections. In addition, its tissue penetration makes it valuable for infections involving bone and deep soft tissue. Because of this profile, Vericlin suits dental, surgical, and general practice settings managing anaerobic or resistant bacterial infections.

Key Features:

• Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 300mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies